Our molecular biology lab is at the forefront of cancer research, focusing on the genetic and epigenetic factors that contribute to cancer development and progression. Utilizing technologies such as CRISPR-Cas9 for gene editing and next-generation sequencing for genomic analysis, we aim to identify novel biomarkers and therapeutic targets. Our integrative approach combines molecular biology with computational analysis, providing a comprehensive view of cancer at the molecular level.
